Heterogeneity of transcription factor expression and regulation in human airway epithelial and smooth muscle cells

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 293, Issue 2, 2007, Pages

  Panebra, Alfredo ^a   Schwarb, Mary Rose ^a   Glinka, Clare B ^a   Liggett, Stephen B ^a,b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b HSF II   (United States)

Author keywords

agonist; Asthma; Inflammation; Transcription

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; INTERLEUKIN 13; INTERLEUKIN 4; LEUKOTRIENE D4; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NUCLEAR FACTOR Y; OLIGONUCLEOTIDE; PAIRED BOX TRANSCRIPTION FACTOR; PROTEIN P300; PROTEIN P53; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 2; TRANSCRIPTION FACTOR E2F; TRANSCRIPTION FACTOR EGR 1; TRANSCRIPTION FACTOR ELK 1; TRANSCRIPTION FACTOR FOXD3; TRANSCRIPTION FACTOR FOXF2; TRANSCRIPTION FACTOR FOXI1; TRANSCRIPTION FACTOR FOXO4; TRANSCRIPTION FACTOR GATA 1; TRANSCRIPTION FACTOR GATA 2; TRANSCRIPTION FACTOR NF E2; TRANSCRIPTION FACTOR PAX4A; TRANSCRIPTION FACTOR PAX6; TRANSCRIPTION FACTOR PAX8; TRANSCRIPTION FACTOR SP1; TRANSCRIPTION FACTOR YY1; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; UNINDEXED DRUG; UPSTREAM STIMULATORY FACTOR 1;

ARTICLE; ASTHMA; CELL CULTURE; CELL NUCLEUS; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; INFLAMMATION; MOLECULAR RECOGNITION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REGULATORY MECHANISM; RESPIRATORY EPITHELIUM; SMOOTH MUSCLE FIBER;

ASTHMA; CELL LINE; EPITHELIAL CELLS; GENE EXPRESSION PROFILING; GENETIC HETEROGENEITY; HUMANS; MYOCYTES, SMOOTH MUSCLE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PNEUMONIA; RESPIRATORY MUCOSA; TRANSCRIPTION FACTORS;

EID: 34547613694     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.00084.2007     Document Type: Article

References (26)

1. Auphan N, DiDonato JA, Rosette C, Helmberg A, Karin M. Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science 270: 286-290, 1995.
2. Barnes PJ. Transcription factors in airway diseases. Lab Invest 86: 867-872, 2006.
3. Barnes PJ, Adcock IM. Transcription factors and asthma. Eur Respir J 12: 221-234, 1998.
4. Beasley R, Pearce N, Crane J, Burgess C. Beta-agonists: what is the evidence that their use increases the risk of asthma morbidity and mortality? J Allergy Clin Immunol 103: S18-S30, 1999.
5. Deshpande DA, Penn RB. Targeting G protein-coupled receptor signaling in asthma. Cell Signal 18: 2105-2120, 2006.
6. 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness. Proc Natl Acad Sci USA 97: 10483-10488, 2000.
7. 2-adrenergic receptor impart distinct agonist-promoted regulatory properties. Biochemistry 33: 9414-9419, 1994.
8. 2-adrenergic receptor genotypes on signal transduction in human airway smooth muscle cells. Am J Respir Cell Mol Biol 13: 25-33, 1995.
9. Hackett TL, Knight DA. The role of epithelial injury and repair in the origins of asthma. Curr Opin Allergy Clin Immunol 7: 63-68, 2007.
10. Jiang X, Roth L, Lai C, Li X. Profiling activities of transcription factors in breast cancer cell lines. Assay Drug Dev Technol 4: 293-305, 2006.
11. Koch A, Raidl M, Lux M, Muller K, Buning H, Humme S, Erdmann E. IL-12-induced T-bet expression and IFNgamma release in lymphocytes from asthmatics-Role of MAPkinases ERK-1/-2, p38(MAPK) and effect of dexamethasone. Respir Med 101: 1321-1330, 2007.
12. Liddiard K, Welch JS, Lozach J, Heinz S, Glass CK, Greaves DR. Interleukin-4 induction of the CC chemokine TARC (CCL17) in murine macrophages is mediated by multiple STAT6 sites in the TARC gene promoter. BMC Mol Biol 7: 45, 2006.
13. Maniatis T, Goodbourn S, Fischer JA. Regulation of inducible and tissue-specific gene expression. Science 236: 1237-1245, 1987.
14. 2-adrenergic receptor. Cell Signal 10: 197-204, 1998.
15. Mialet-Perez J, Green SA, Miller WE, Liggett SB. A primate-dominant third glycosylation site of the β2-adrenergic receptor routes receptors to degradation during agonist regulation. J Biol Chem 279: 38603-38607, 2004.
16. Nakamura Y, Hoshino M. TH2 cytokines and associated transcription factors as therapeutic targets in asthma. Curr Drug Targets Inflamm Allergy 4: 267-270, 2005.
17. Nelson HS, Weiss ST, Bleecker ER, Yancey SW, Dorinsky PM. The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol. Chest 129: 15-26, 2006.
18. Nikolov DB, Burley SK. RNA polymerase II transcription initiation: a structural view. Proc Natl Acad Sci USA 94: 15-22, 1997.
19. Panebra A, Schwarb MR, Glinka CB, Liggett SB. Allele-specific binding of airway nuclear extracts to polymorphic β2-adrenergic receptor 5′-sequence. Am J Respir Cell Mol Biol 36: 654-660, 2007.
20. Popescu FD. New asthma drugs acting on gene expression. J Cell Mol Med 7: 475-486, 2003.
21. Roth M, Black JL. Transcription factors in asthma: are transcription factors a new target for asthma therapy? Curr Drug Targets 7: 589-595, 2006.
22. Sears MR. Role of β-agonists in asthma fatalities. In: Fatal asthma, edited by Sheffer AL. New York: Marcel Dekker, 1998, p. 457-481.
23. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ, Klenk DC. Measurement of protein using bicinchoninic acid. Anal Biochem 150: 76-85, 1985.
24. Szabo SJ, Kim ST, Costa GL, Zhang X, Fathman CG, Glimcher LH. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 100: 655-669, 2000.
25. van der Woude HJ, Winter TH, Aalbers R. Decreased bronchodilating effect of salbutamol in relieving methacholine induced moderate to severe bronchoconstriction during high dose treatment with long acting beta2 agonists. Thorax 56: 529-535, 2001.
26. Zawel L, Reinberg D. Initiation of transcription by RNA polymerase II: a multi-step process. Prog Nucleic Acid Res Mol Biol 44: 67-108, 1993.